Vascular Magnetics, Inc. is magnetically targeting drug-loaded biodegradable nanoparticles to develop Vascular Magnetic Intervention (VMI), a novel therapy for peripheral artery disease (PAD). PAD is a common chronic condition characterized by obstruction (stenosis) of the arteries in the legs.
The company is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of choice for vascular atherosclerosis as well as non-vascular applications.
Velocys, Inc. is commercializing revolutionary processing systems, including nanoscale ones, that provide energy companies with new synthetic fuels and chemical companies with substantial capital cost savings, improved product yields, and greater energy efficiencies.
VeriCold Technologies is specialized in cutting-edge X-ray spectroscopy and cooling solutions. Driven by innovative markets (semiconductor, biotechnology and nanotechnology) VeriCold's technology is a key-enabler for new processes in manufacturing, quality control and research.
Vistec Semiconductor Systems' innovative product portfolio includes inspection systems, defect detection and classification, metrology systems for mask and wafer manufacturing. The electron beam systems are used for microchip production and integrated optics as well as for scientific and commercial research.
Offers new culture and exposure systems for in vitro studies of gases or complex mixtures. The VITROCELL modules offer new possibilities for the characterization of the effects of airborne substances such as gases nanoparticles and complex mixtures.
WaferGen Biosystems, Inc. is a leader in the development, manufacture and commercialization of next-generation systems for gene expression, genotyping, stem cell research and cell biology for the life science and pharmaceutical industries.
WaveSense develops, manufactures, and markets breakthrough analytical nanotechnologies for use in cellular and molecular assay markets. The company's patented and hierarchy technology is called Xenographic Retention Chromatography (XRC) - branded as EpiSep, which is a lateral flow separations platform that provides rapid, advanced detection and characterization of live cells, proteins, and/or genes. Researchers can then harvest the targets for interrogation purposes within their desired application.